These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34617262)

  • 1. Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling.
    Gerhart JG; Carreño FO; Edginton AN; Sinha J; Perrin EM; Kumar KR; Rikhi A; Hornik CP; Harris V; Ganguly S; Cohen-Wolkowiez M; Gonzalez D;
    Clin Pharmacokinet; 2022 Feb; 61(2):307-320. PubMed ID: 34617262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologically Based Pharmacokinetic Modeling for Trimethoprim and Sulfamethoxazole in Children.
    Thompson EJ; Wu H; Maharaj A; Edginton AN; Balevic SJ; Cobbaert M; Cunningham AP; Hornik CP; Cohen-Wolkowiez M
    Clin Pharmacokinet; 2019 Jul; 58(7):887-898. PubMed ID: 30840200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing Pharmacokinetics in Children With Obesity-Physiological, Drug, Patient, and Methodological Considerations.
    Gerhart JG; Balevic S; Sinha J; Perrin EM; Wang J; Edginton AN; Gonzalez D
    Front Pharmacol; 2022; 13():818726. PubMed ID: 35359853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children.
    Autmizguine J; Melloni C; Hornik CP; Dallefeld S; Harper B; Yogev R; Sullivan JE; Atz AM; Al-Uzri A; Mendley S; Poindexter B; Mitchell J; Lewandowski A; Delmore P; Cohen-Wolkowiez M; Gonzalez D;
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Dosing and Pharmacokinetics in Children With Obesity: A Systematic Review.
    Harskamp-van Ginkel MW; Hill KD; Becker KC; Testoni D; Cohen-Wolkowiez M; Gonzalez D; Barrett JS; Benjamin DK; Siegel DA; Banks P; Watt KM;
    JAMA Pediatr; 2015 Jul; 169(7):678-85. PubMed ID: 25961828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Real-World Data and Physiologically-Based Pharmacokinetic Modeling to Characterize Enoxaparin Disposition in Children With Obesity.
    Gerhart JG; Carreño FO; Loop MS; Lee CR; Edginton AN; Sinha J; Kumar KR; Kirkpatrick CM; Hornik CP; Gonzalez D;
    Clin Pharmacol Ther; 2022 Aug; 112(2):391-403. PubMed ID: 35451072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of physiologically-based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity.
    Gerhart JG; Carreño FO; Ford JL; Edginton AN; Perrin EM; Watt KM; Muller WJ; Atz AM; Al-Uzri A; Delmore P; Gonzalez D;
    CPT Pharmacometrics Syst Pharmacol; 2022 Jun; 11(6):778-791. PubMed ID: 35491971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes in patients hospitalized with cellulitis treated with oral clindamycin and trimethoprim/sulfamethoxazole: The role of weight-based dosing.
    Cox KK; Alexander B; Livorsi DJ; Heintz BH
    J Infect; 2017 Dec; 75(6):486-492. PubMed ID: 28919346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of a generic physiologically based pharmacokinetic model for children.
    Edginton AN; Schmitt W; Willmann S
    Clin Pharmacokinet; 2006; 45(10):1013-34. PubMed ID: 16984214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Pediatric Physiologically-Based Pharmacokinetic Model of Clindamycin Using Opportunistic Pharmacokinetic Data.
    Hornik CP; Wu H; Edginton AN; Watt K; Cohen-Wolkowiez M; Gonzalez D
    Clin Pharmacokinet; 2017 Nov; 56(11):1343-1353. PubMed ID: 28290120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patients.
    Chin TW; Vandenbroucke A; Fong IW
    Antimicrob Agents Chemother; 1995 Jan; 39(1):28-33. PubMed ID: 7695325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The integration of allometry and virtual populations to predict clearance and clearance variability in pediatric populations over the age of 6 years.
    Edginton AN; Shah B; Sevestre M; Momper JD
    Clin Pharmacokinet; 2013 Aug; 52(8):693-703. PubMed ID: 23588537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT.
    Ben Hassine K; Seydoux C; Khier S; Daali Y; Medinger M; Halter J; Heim D; Chalandon Y; Schanz U; Nair G; Cantoni N; Passweg JR; Satyanarayana Uppugunduri CR; Ansari M
    Transplant Cell Ther; 2024 Mar; 30(3):332.e1-332.e15. PubMed ID: 38081414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.
    Safrin S; Finkelstein DM; Feinberg J; Frame P; Simpson G; Wu A; Cheung T; Soeiro R; Hojczyk P; Black JR
    Ann Intern Med; 1996 May; 124(9):792-802. PubMed ID: 8610948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants.
    Ganguly S; Edginton AN; Gerhart JG; Cohen-Wolkowiez M; Greenberg RG; Gonzalez D;
    Clin Pharmacokinet; 2021 Dec; 60(12):1591-1604. PubMed ID: 34155614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractal Geometry-Based Decrease in Trimethoprim-Sulfamethoxazole Concentrations in Overweight and Obese People.
    Hall RG; Pasipanodya JG; Meek C; Leff RD; Swancutt M; Gumbo T
    CPT Pharmacometrics Syst Pharmacol; 2016 Dec; 5(12):674-681. PubMed ID: 27869362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines.
    Pressiat C; Mea-Assande V; Yonaba C; Treluyer JM; Dahourou DL; Amorissani-Folquet M; Blanche S; Eboua F; Ye D; Lui G; Malateste K; Zheng Y; Leroy V; Hirt D;
    Br J Clin Pharmacol; 2017 Dec; 83(12):2729-2740. PubMed ID: 28800382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a paediatric population-based model of the pharmacokinetics of rivaroxaban.
    Willmann S; Becker C; Burghaus R; Coboeken K; Edginton A; Lippert J; Siegmund HU; Thelen K; Mück W
    Clin Pharmacokinet; 2014 Jan; 53(1):89-102. PubMed ID: 23912563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of normalized prediction distribution errors for assessing population physiologically-based pharmacokinetic model adequacy.
    Maharaj AR; Wu H; Hornik CP; Arrieta A; James L; Bhatt-Mehta V; Bradley J; Muller WJ; Al-Uzri A; Downes KJ; Cohen-Wolkowiez M
    J Pharmacokinet Pharmacodyn; 2020 Jun; 47(3):199-218. PubMed ID: 32323049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.